Qi Jiang has over a decade of experience in material and analytical sciences, currently serving as Principal Scientist at Boehringer Ingelheim since November 2015. In this role, Qi Jiang provides CMC support and scientific leadership across various drug candidate developments, focusing on solid form assessments and polymorph evaluations. Prior to this, Qi Jiang held positions as Senior Scientist and Research Assistant, contributing expertise in solid-state form selection and crystallization techniques at New York University, where teaching roles included undergraduate courses in chemistry. Educational qualifications include a Ph.D. in Chemistry from New York University, a Master’s from Rutgers University, and two additional Master’s degrees and Bachelor's degrees from Nanjing University, highlighting a strong foundational expertise in chemistry and physical chemistry.
This person is not in the org chart
This person is not in any teams